| AASLD

Establishment of a Patient‐Derived Xenograft Tumor From Hepatitis C–Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy

Read more about Establishment of a Patient‐Derived Xenograft Tumor From Hepatitis C–Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy

Mustafa Nazzal, Subhayan Sur, Robert Steele, Mousumi Khatun, Tapas Patra, Nancy Phillips, John Long, Ranjit Ray, Ratna B. Ray – 1 May 2020

Resection of Mixed Hepatocellular‐Cholangiocarcinoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma

Read more about Resection of Mixed Hepatocellular‐Cholangiocarcinoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma

Matthew L. Holzner, Parissa Tabrizian, Fatemeh P. Parvin‐Nejad, Kezhen Fei, Ganesh Gunasekaran, Chiara Rocha, Marcelo E. Facciuto, Sander Florman, Myron E. Schwartz – 30 April 2020 – Mixed hepatocellular‐cholangiocarcinoma (HCC‐CC) is a biphenotypic liver cancer thought to have unfavorable tumor biology and a poor prognosis. Surgical outcomes of HCC‐CC remain unclear. We aimed to evaluate the clinical characteristics and surgical outcomes of HCC‐CC.